Notice of AGM and Report and Accounts

RNS Number : 2685W

Avacta Group PLC

23 December 2013

 



Avacta Group plc

("Avacta" or the "Group")

Notice of AGM and Report and Accounts

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, today announces that copies of the Annual Report and Accounts for the year ended 31 July 2013 have been sent to shareholders along with the Notice of Annual General Meeting ('AGM'). Copies of both documents are also available of the Company's website, www.avacta.com.

The AGM will be held at the offices of Walker Morris, Kings Court, 12 King Street, Leeds, LS1 2HL on 24 January 2014 at 2.00pm.

- Ends -

Enquiries:

Avacta Group plc	www.avacta.com
Alastair Smith, Chief Executive Officer	Tel:  [phone]
Tim Sykes, Chief Financial Officer
Numis Securities Limited		Tel:  [phone]
Michael Meade / Freddie Barnfield (NOMAD)
James Black  (Corporate Broking)
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Mike Wort	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

About Avacta Group plc - www.avacta.com

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

Avacta Analytical www.avactaanalytical.com	High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.
Avacta Animal Health www.avactaanimalhealth.com	Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.
Avacta Life Sciences www.avactalifesciences.com	Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

Avacta joined AIM in August 2006 and is based in Wetherby, England.

 

END

 

 

MSCFEAFLDFDSEIE